Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena Friedl

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|March 14, 2019
PLATYPUS: A Multiple-View Learning Predictive Framework for Cancer Drug Sensitivity PredictionKiley Graim, Verena Friedl, Kathleen E Houlahan, et al.
Cell Reports Methods|June 18, 2024
Single-cell signatures identify microenvironment factors in tumors associated with patient outcomesYuanqing Xue, Verena Friedl, Hongxu Ding, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 5, 2019
Using Transcriptional Signatures to Find Cancer Drivers with LUREDavid Haan, Ruikang Tao, Verena Friedl, et al.
Prostate Cancer and Prostatic Diseases|April 15, 2020
Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancerRahul Aggarwal, Gustavo Rubio Romero, Verena Friedl, et al.
The Journal of Molecular Diagnostics : JMD|September 4, 2024
Analytical Validation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation SignaturesShimul Chowdhury, Michael Kesling, Micah Collins, et al.
Communications Biology|November 19, 2025
5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNAYuan Xue, Yuhong Ning, Verena Friedl, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2023
Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNADavid Haan, Anna Bergamaschi, Verena Friedl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective StudyRahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|March 14, 2019
PLATYPUS: A Multiple-View Learning Predictive Framework for Cancer Drug Sensitivity PredictionKiley Graim, Verena Friedl, Kathleen E Houlahan, et al.
Cell Reports Methods|June 18, 2024
Single-cell signatures identify microenvironment factors in tumors associated with patient outcomesYuanqing Xue, Verena Friedl, Hongxu Ding, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 5, 2019
Using Transcriptional Signatures to Find Cancer Drivers with LUREDavid Haan, Ruikang Tao, Verena Friedl, et al.
Prostate Cancer and Prostatic Diseases|April 15, 2020
Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancerRahul Aggarwal, Gustavo Rubio Romero, Verena Friedl, et al.
The Journal of Molecular Diagnostics : JMD|September 4, 2024
Analytical Validation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation SignaturesShimul Chowdhury, Michael Kesling, Micah Collins, et al.
Communications Biology|November 19, 2025
5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNAYuan Xue, Yuhong Ning, Verena Friedl, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2023
Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNADavid Haan, Anna Bergamaschi, Verena Friedl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective StudyRahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Pageof 2